Prevention of Ventricular Arrhythmia and Calcium Dysregulation in a Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model Carrying Calsequestrin-2 Mutation

Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia

(2009) Meiso Hayashi et al.   CIRCULATION

Intra-sarcoplasmic reticulum Ca2+oscillations are driven by dynamic regulation of ryanodine receptor function by luminal Ca2+in cardiomyocytes

(2009) Sarah C.W. Stevens et al.   JOURNAL OF PHYSIOLOGY-LONDON

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

(2009) Hiroshi Watanabe et al.   NATURE MEDICINE

Video-Assisted Thoracoscopic Cardiac Denervation: A Potential Novel Therapeutic Option for Children With Intractable Ventricular Arrhythmias

(2008) Joseph Atallah et al.   ANNALS OF THORACIC SURGERY

Caffeine induces Ca2+release by reducing the threshold for luminal Ca2+activation of the ryanodine receptor

(2008) Huihui Kong et al.   BIOCHEMICAL JOURNAL

Modulation of SR Ca Release by Luminal Ca and Calsequestrin in Cardiac Myocytes: Effects of CASQ2 Mutations Linked to Sudden Cardiac Death

(2008) Dmitry Terentyev et al.   BIOPHYSICAL JOURNAL

Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular Tachycardia

(2008) Arthur A.M. Wilde et al.   NEW ENGLAND JOURNAL OF MEDICINE

Catecholaminergic Polymorphic Ventricular Tachycardia

(2008) Nian Liu et al.   PROGRESS IN CARDIOVASCULAR DISEASES